Research Paper Volume 15, Issue 8 pp 2937—2969
FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
Figure 3. Comparison of survival curves of FARSB overexpression and underexpression in HCC. (A–D) Survival curves for OS, DFS, PFS, and DSS in normal and overall FARSB patients by using Kaplan-Meier Plotter. (E–G) Internal validation of the prognostic model in TCGA cohort based on clinical features by using UALCAN (E) BMI, (F) Gender, (G) Race.